UnitedHealth Group Inc. - 1998 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 1998, for UnitedHealth Group Inc. (UnitedHealthcare Corporation). The Company is a national leader in health care coverage and management services, operating in all 50 states, D.C., Puerto Rico, and internationally. In late 1997, the Company realigned its operations into six strategic business units: UnitedHealthcare, Unimerica, Uniprise, Ovations, Specialized Care Services, and Ingenix. A significant event in 1998 was the commencement of a 10-year contract with the American Association of Retired Persons (AARP) on January 1, 1998, to underwrite Medicare and hospital supplement insurance products.
Key Financial Metrics
| Metric (in millions, except per share) | 1998 | 1997 |
|---|---|---|
| Total Revenues | $17,355 | $11,794 |
| Net Earnings (Loss) | $(166) | $460 |
| Net Earnings (Loss) Applicable to Common Shareholders | $(214) | $431 |
| Diluted EPS (Loss) | $(1.12) | $2.26 |
| Operating Cash Flow | $1,071 | $683 |
| Total Assets | $9,701 | $7,623 |
| Total Debt | $708 | $0 |
| Shareholders' Equity | $4,038 | $4,534 |
| Medical Care Ratio | 87.2% | 84.3% |
| SG&A Ratio | 17.1% | 20.0% |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 47% to $17.4 billion, driven primarily by the new AARP business ($3.5 billion in premiums) and 16% same-store enrollment growth in UnitedHealthcare.
- Net Loss: The Company reported a net loss of $166 million compared to $460 million in net earnings in 1997. This reversal was caused by $900 million in special charges:
- $725 million in operational realignment charges (asset impairments, severance, lease obligations).
- $175 million in charges related to contract losses in Medicare markets and increased medical cost estimates.
- $20 million redemption premium on convertible preferred stock.
- Underlying Performance: Excluding the special charges, underlying earnings from operations were $858 million (up 16% from 1997), and diluted EPS would have been $2.62.
- Capital Structure: The Company redeemed $500 million of convertible preferred stock and issued $708 million in new debt (notes and commercial paper) to fund the redemption and repurchase 11.3 million shares of common stock.
- Medical Costs: The medical care ratio increased to 87.2% from 84.3%, largely due to the inclusion of the AARP business (approx. 92% ratio) and higher-than-expected costs in Medicare markets.
Guidance, Outlook, and Risks
- Operational Realignment: Management expects the realignment plan to reduce the overall cost structure by approximately $300 million annually by the end of 2000, with $75 million realized in 1999.
- Medicare Strategy: The Company announced a withdrawal of Medicare product offerings from 86 counties (affecting 13% of Medicare members) effective January 1, 1999, due to unprofitability. They will focus on strong, economically viable markets.
- Outlook for 1999: Management expects average medical cost increases to remain stable at 4-5%. They anticipate an improved medical care ratio driven by premium yield increases of 7-8% on new and renewal commercial business.
- Year 2000 Compliance: The Company is on schedule to complete remediation by September 30, 1999. Projected total costs are $79 million. Risks include business interruption if critical vendors or providers are non-compliant.
- Legal Proceedings: Six securities class-action lawsuits are pending, alleging false statements regarding Medicare profitability and realignment expenses. Two pension funds have filed separate actions seeking approximately $12.1 million. Management intends to defend vigorously and does not believe these will have a material adverse effect.
- Regulatory Risks: The business is heavily regulated. Changes in Medicare/Medicaid reimbursement, HIPAA implementation, and state insurance laws could adversely affect operations and financial results.
Key Facts for Investor Verification
- Adjusted Earnings: Verify the calculation of "underlying" earnings ($858 million operating income) excluding the $900 million in special charges to assess core business performance.
- Medicare Exit Strategy: Monitor the financial impact of exiting 86 Medicare counties and the ability to achieve profitability in remaining markets.
- Medical Cost Trends: Track the medical care ratio in 1999 to confirm if premium yield increases (7-8%) successfully offset medical cost inflation (4-5%).
- Debt Servicing: Review the impact of the new $708 million debt load on interest coverage ratios and liquidity, given the shift from preferred stock dividends to interest expense.
- Year 2000 Readiness: Confirm the status of critical vendor and provider compliance as the deadline approaches to mitigate business interruption risks.
- Legal Exposure: Monitor the status of the securities litigation regarding Medicare disclosures and realignment costs.